scispace - formally typeset
I

Ivana Nikolic

Researcher at University of Kragujevac

Publications -  66
Citations -  1725

Ivana Nikolic is an academic researcher from University of Kragujevac. The author has contributed to research in topics: Apoptosis & Cytokine. The author has an hindex of 17, co-authored 58 publications receiving 1371 citations. Previous affiliations of Ivana Nikolic include University of Belgrade & Durham University.

Papers
More filters
Journal ArticleDOI

Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity.

TL;DR: The rosemary extract developed more pronounced antioxidant, cytotoxic and immunomodifying activities, probably due to the presence of betulinic acid and a higher concentration of carnosic acid in its phytochemical profile.
Journal ArticleDOI

Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate.

TL;DR: Although invasive, mediastinoscopy identified locally advanced disease in a significant percentage of this lung cancer population and was associated with a low false negative rate.
Journal ArticleDOI

Galectin-3 Deficiency Accelerates High-Fat Diet–Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets

TL;DR: It is shown that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet–induced obesity and diabetes, and important protective roles for Gal-3 are suggested in obesity-induced inflammation and diabetes.
Journal ArticleDOI

Protective role of IL-33/ST2 axis in Con A-induced hepatitis.

TL;DR: It is concluded that Interleukin 33/ST2 axis downregulated Concanavalin A-induced liver injury and should be evaluated as potential target in fulminant hepatitis in humans.
Journal ArticleDOI

A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension

TL;DR: The findings are consistent with a pathogenetic role of TGF-β1/3, demonstrating the efficacy and tolerability of selective TGF -β ligand blockade for improving hemodynamics, remodeling, and survival in multiple experimental PH models.